DOI:
10.1055/s-00000094
Zeitschrift für Gastroenterologie
LinksClose Window
References
Roy PS, John S, Karankal S et al.
Comparison of the efficacy and safety of Rituximab (Mabthera™) and its biosimilar (Reditux™) in diffuse large B-cell lymphoma patients treated with chemo-immunotherapy: A retrospective analysis.
Indian J Med Paediatr Oncol 2013;
34: 292-298
We do not assume any responsibility for the contents of the web pages of other providers.